- Home
- DTCK vs CLDI Comparison
DTCK vs CLDI Comparison
Compare DTCK & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- CLDI
- Stock Information
- Founded
- DTCK 1999
- CLDI 2014
- Country
- DTCK Singapore
- CLDI United States
- Employees
- DTCK N/A
- CLDI N/A
- Industry
- DTCK Farming/Seeds/Milling
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTCK Industrials
- CLDI Health Care
- Exchange
- DTCK Nasdaq
- CLDI Nasdaq
- Market Cap
- DTCK 21.9M
- CLDI 20.2M
- IPO Year
- DTCK 2023
- CLDI N/A
- Fundamental
- Price
- DTCK $0.91
- CLDI $1.58
- Analyst Decision
- DTCK
- CLDI
- Analyst Count
- DTCK 0
- CLDI 0
- Target Price
- DTCK N/A
- CLDI N/A
- AVG Volume (30 Days)
- DTCK 86.5K
- CLDI 452.5K
- Earning Date
- DTCK 11-12-2025
- CLDI 11-11-2025
- Dividend Yield
- DTCK N/A
- CLDI N/A
- EPS Growth
- DTCK N/A
- CLDI N/A
- EPS
- DTCK N/A
- CLDI N/A
- Revenue
- DTCK $132,369,000.00
- CLDI N/A
- Revenue This Year
- DTCK N/A
- CLDI N/A
- Revenue Next Year
- DTCK N/A
- CLDI N/A
- P/E Ratio
- DTCK N/A
- CLDI N/A
- Revenue Growth
- DTCK N/A
- CLDI N/A
- 52 Week Low
- DTCK $0.40
- CLDI $1.51
- 52 Week High
- DTCK $1.50
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- DTCK 56.56
- CLDI 30.67
- Support Level
- DTCK $0.88
- CLDI $1.51
- Resistance Level
- DTCK $0.94
- CLDI $1.68
- Average True Range (ATR)
- DTCK 0.07
- CLDI 0.08
- MACD
- DTCK 0.01
- CLDI 0.16
- Stochastic Oscillator
- DTCK 64.25
- CLDI 30.35
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.